Features of the psychosomatic state in lung cancer patients and psychopathophysiological aspects of cardiovascular diseases
Автор: Zhukova Galina V., Shikhlyarova Alla I., Maschenko Natalia М., Shirnina Elena А., Zinkovich Mikhail S., Airapetova Tamara G., Anistratov Pavel А., Rozenko Lyudmila Y., Vaschenko Larisa N., Burtsev Dmitry V., Gusareva Marina А., Kozyuk Olga V., Shevchenko Aleksey N.
Журнал: Cardiometry @cardiometry
Рубрика: Original research
Статья в выпуске: 13, 2018 года.
Бесплатный доступ
Aim The aim hereof is a comprehensive study of the mental, adaptive and hormonal status in patients with lung cancer with varying prevalence of the malignant process. The obtained results are compared with data on the psychosomatic state and subclinical disorders in the thyroid system in patients with cardiovascular diseases.
Lung tumors, general non-specific adaptation reaction, euphoric reaction, depression, thyroxine, cardiovascular disease
Короткий адрес: https://sciup.org/148308859
IDR: 148308859 | DOI: 10.12710/cardiometry.2018.13.8695
Список литературы Features of the psychosomatic state in lung cancer patients and psychopathophysiological aspects of cardiovascular diseases
- Demin EV, Gnezdilov AV, Chulkova VA. Psycho-oncology: the formation and development prospects. Voprosi onkologii. 2011;57(1):86-91.
- Holland JC. Psycho-Oncology: overview, obstacles and opportunities. Psycho-Oncology. 1992:1(1):1-13
- Buhtoyarov OV, Samarin DM. The unity of mind and body -the concept of dominant life goals. World of psychology. Moscow. 2010;3:210-20.
- Massie MJ, Miller K. Oncology. In: James L., Levenson M.D., editors. Textbook of psychosomatic medicine. Washington, DC, London, England: American Psychiatric Publishing, Inc., 2005. P.517-534
- Dil'man V.M. Four models of medicine. Leningrad: Medicina, 1987. 284p.
- Garkavi LH. Activation therapy. Rostov-on-Don. 2006. 256 p.
- Drobizhev MY. Cardiopsychiatry. Clash of opinions. Cardiovascular Therapy and Prevention. 2017; 16(2):84-7.
- Garkavi LH, Kvakina EB, Ukolova MA. Adaptation reactions and body resistance. Rostov-on-Don. 1990. 223 p.
- Selye H. Thymus and adrenals in the response of the organisms to injuries and intoxication. Brit. J. Exp. Path. 1936;17:234-48.
- Garkavi LH, Kuzmenko TS, Maschenko NM. Expert system "Antistress". Medical Information Systems. Taganrog, 1995;5:13-6.
- Zhilyaeva TV. Psychopathological and social psychological characteristics of oncology patients on the stage of diagnostics and treatment in hospitals. Dissertation. Moscow. 2008. 191p.
- Vasserman LI, Iovlev BV, Karpova EB. Psychological diagnosis of the relationship to the disease. Manual for doctors. SPb. 2005.
- Nadolnik LI. Stress and thyroid gland. Biomedical chemistry. 2010;56(4):443-56. [in Russian
- Bistrova TV, Troshina EA, Abdulhabirova FM. Subclinical thyrotoxicosis and cardiovascular system. Clinical and experimental thyroidology. 2006;2(2):38-42
- Demidova TY, Drozdova IN, Potehin NP, Orlov FA. Subclinical thyrotoxicosis and cardiovascular system. Endocrinology. News. Opinions. Training. 2017;2:16-21.
- Jabbar A, Pingitore A, Pearce SH, et al. Thyroid hormones and cardiovascular disease. Nat. Rev. Cardiol. 2017;1:39-55. Epub 2016 Nov 4 DOI: 10.1038/nrcardio.2016.174
- Jabbar A, Ingoe L, Pearce S, Zaman A, Razvi S. Thyroxine in acute myocardial infarction (ThyrAMI) -levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial. Trials. 2015;16:115.
- Razvi S, Jabbar A, Pingitore A, et al. Thyroid Hormones and Cardiovascular Function and Diseases. J. Am. Coll. Cardiol. 2018;71(16):1781-96
- Sapronov NS, Maslova OO. Neurophysiological effects of thyroid hormones. Psychopharmacology and Biological Addiction Medicine. 2007;7(2):1533-41.
- Larsen PR, Frumess RD. Comparison of the biological effects of thyroxine and triiodothyronine in the rat. Endocrinology. 1977;100(4): 980-8.
- Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N. Engl. J. Med. 1999;340(6):424-9.
- Baumgartner A. Thyrоxine and the treatment of affective disorders: an overview of the results of basic and clinical researches. Int. J. Neuropsychopharmacol. 2000;3(2):149-65.
- Smulevich AB, Syrkin AL, Drobizhev MY, Ivanov SV. Psihokardiologiya. Moscow: MIA, 2005. 779 p.
- Smulevich AB. Depression in cardiovascular diseases. Mental disorders in general medicine. 2013;4:4-9.
- Kupper N, Denollet J, Widdershoven J, Kop WJ. Cardiovascular Reactivity to Mental Stress and Mortality in Patients With Heart Failure. JACC: Heart Failure. 2015;3(5) DOI: 10.1016/j.jchf.2014.12.016
- Kopylov FYu. Psychosomatic aspects of cardiovascular diseases (hypertension, coronary heart disease, atrial fibrillation). Dissertation. Moscow, 2009. 220p
- Solov'eva IK. Afobazol as a drug of choice in psychocardiology. RMZH. 2018;7:1438.
- Roest AM, Martens EJ, Denollet J, et al. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med. 2010;72:563-9
- Blankova ZN, Ageev FT, Seredenina EM, Ret sl. SHCH. Gipotireoz i serdechno-sosudistye zabolevaniya. RMZH. 2014;13:980
- Erem C. Thyroid disorders and hypercoagulability. Semin. Thromb. Hemost. 2011; 37(1):17-26
- Gulseren S, Gulseren L, Hekimsoy Z, et al. Depression, anxiety, health related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Archiv. Medic. Research. 2006;37(1):133-9
- Kit OI, Shikhlyarova AI, Maryanovskaya GY, et al. Theory of health: successful translation into the real life. Cardiometry. 2015;7:11-7 DOI: 10.12710/cardiometry.2015.7.1117
- Kit OI, Shikhlyarova AI, Zhukova GV, et al. Activation therapy: theoretical and applied aspects. Cardiometry. 2015;7:22-9 DOI: 10.12710/cardiometry.2015.7.2229
Статья научная
